On November 2, 2021, Pfizer conducted a COVID-19 vaccine trial on 2,250 kids 5 to 12 years of age. Pfizer administered a 10ug dose of BNT162 to 1500 kids and a placebo to the remaining 750. The group was split 50/50 male to female with a primarily white demographic (79.3%) and the follow up time after administration of the vaccine was 2.3 months. The premise of the entire trial is difficult to wrap your head around. Why is Pfizer running a clinical trial on an age group that is proven to have little to no chance of contracting and spreading COVID-19 in the first place? They boast that the results proved a 90% efficacy rate but if kids aren’t contracting COVID-19 in the first place, that refutes the premise of the trial. Interesting.
Let’s take a look at the systemic events, by maximum severity, within 7 days after dose 2 in 5 to <12 year olds. 98 kids (6.5%) experienced a mild fever after administration. 591 kids (39.4%) experienced fatigue, 420 (28%) experienced headaches, 147 (9.8%) had chills, 30 kids (2%) were vomiting, 80 kids (5.3%) had diarrhea, 176 (11.7%) experienced muscle pain and 78 (5.2%) experienced joint pain. After reading these statistics would you get your child vaccinated and let them incur these definite effects? As it is, kids are half as likely to contract COVID-19 compared to adults <20. Dr.Robert Hamilton says, “Around the world, study after study has shown that children and adolescents account for only 1 to 3 percent of all cases, and that even fewer ultimately require hospitalization,”. It clearly looks like the vaccine itself puts kids 5-12 years of age at higher risk of health problems than COVID-19.
